GT Biopharma

GTBPNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$14.193 M

$0.32 +6.35%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$28.4M

Loss-making

Shares outstanding

31,553,892

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#416Cocrystal PharmaCOCP$14.6M
#417Kala BioKALA$14.5M
#418GT BiopharmaGTBP$14.2M
#419Chemomab TherapeuticsCMMB$13.9M
#420Palatin TechnologiesPTN$13.8M

Where these numbers come from

Share counts and financials for GT Biopharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.